Clinical Trial Update: Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of tislelizumab with gemcitabine and cisplatin for relapsed/refractory Hodgkin lymphoma, followed by tislelizumab consolidation in metabo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland | Conditions: Hodgkin Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING